Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zuqamu Granules (祖卡木颗粒) is a Traditional Chinese Medicine (TCM) and Uighur medicinal preparation widely used in China for the symptomatic relief of the common cold, cough, fever, and sore throat. The formulation is a complex herbal combination that typically includes botanical extracts such as poppy shell (*Papaveris Pericarpium*), marshmallow root (*Althaea officinalis*), licorice (*Glycyrrhiza uralensis*), and white water lily (*Nymphaea candida*). Due to the presence of alkaloids from the poppy shell, including morphine and codeine, the drug acts as a central antitussive and analgesic. Because of these active components, post-marketing safety evaluations, such as those conducted by Union Hospital of Tongji Medical College, specifically monitor for potential physical and psychological drug dependence and other adverse reactions in real-world clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zuqamu Granules.